Facilitated intracellular delivery of peptide-guided nanoparticles in tumor tissues

Journal of Controlled Release

Volumn 157, Issue 3, 2012, Pages 493-499

  Kim, Jong Ho ^a   Bae, Sang Mun ^a   Na, Moon Hee ^a   Shin, Hyeri ^a   Yang, Yu Jin ^a   Min, Kyung Hyun ^b   Choi, Ki Young ^b   Kim, Kwangmeyung ^b   Park, Rang Woon ^a   Kwon, Ick Chan ^b   Lee, Byung Heon ^a   Hoffman, Allan S ^a,c   Kim, In San ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

^c University of Washington   (United States)

Author keywords

Cancer imaging; Cancer therapy; Homing peptide; Nanoparticles; Tumor targeting

Indexed keywords

BINDING PEPTIDE; CANCER IMAGING; CANCER THERAPY; CELLULAR UPTAKE; ENHANCED PERMEABILITY; HOMING PEPTIDE; HYDROPHOBICALLY MODIFIED GLYCOL CHITOSANS; INTERLEUKIN-4 RECEPTORS; INTRACELLULAR DELIVERY; NONCONJUGATED; PASSIVE TARGETING; THERAPEUTIC EFFICACY; TUMOR TARGETING; TUMOR TISSUES; TUMOR VESSELS;

DRUG DELIVERY; GLYCOLS; HISTOLOGY; MEDICAL IMAGING; PEPTIDES; TUMORS;

NANOPARTICLES;

CHITOSAN; GLYCOL CHITOSAN; INTERLEUKIN 4 RECEPTOR; NANOPARTICLE; PACLITAXEL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TISSUE; CHEMICAL STRUCTURE; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CHITOSAN; DRUG CARRIERS; HUMANS; MICE; MICE, NUDE; NANOPARTICLES; NEOPLASM TRANSPLANTATION; NEOPLASMS; OLIGOPEPTIDES; PACLITAXEL; RECEPTORS, INTERLEUKIN-4; TUMOR BURDEN;

EID: 84857374141     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.09.070     Document Type: Article

References (29)

1. W. Arap, R. Pasqualini, and E. Ruoslahti Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model Science 279 1998 377 380 (Pubitemid 28063372)
2. I. Brigger, C. Dubernet, and P. Couvreur Nanoparticles in cancer therapy and diagnosis Adv. Drug Deliv. Rev. 54 2002 631 651 (Pubitemid 35247520)
3. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 1986 6387 6392 (Pubitemid 17221789)
4. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2 2007 751 760 (Pubitemid 350223348)
5. D.A. Scheinberg, C.H. Villa, F.E. Escorcia, and M.R. McDevitt Conscripts of the infinite armada: systemic cancer therapy using nanomaterials Nat. Rev. Clin. Oncol. 7 2010 266 276
6. J.H. Kang, R. Toita, and Y. Katayama Bio and nanotechnological strategies for tumor-targeted gene therapy Biotechnol. Adv. 2010
7. S. Kwon, J.H. Park, H. Chung, I.C. Kwon, S.Y. Jeong, and I.S. Kim Physicochemical characteristics of self-assembled nanoparticles based on glycol chitosan bearing 5 beta-cholanic acid Langmuir 19 2003 10188 10193
8. K. Park, H.Y. Hong, H.J. Moon, B.H. Lee, I.S. Kim, I.C. Kwon, and K. Rhee A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides J. Control. Release 128 2008 217 223
9. J.H. Kim, Y.S. Kim, S. Kim, J.H. Park, K. Kim, K. Choi, H. Chung, S.Y. Jeong, R.W. Park, I.S. Kim, and I.C. Kwon Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel J. Control. Release 111 2006 228 234 (Pubitemid 43290012)
10. K. Kawakami, P. Leland, and R.K. Puri Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells Cancer Res. 60 2000 2981 2987 (Pubitemid 30395824)
11. M. Kawakami, K. Kawakami, V.A. Stepensky, R.A. Maki, H. Robin, W. Muller, S.R. Husain, and R.K. Puri Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy Clin. Cancer Res. 8 2002 3503 3511 (Pubitemid 35340728)
12. N.I. Obiri, G.G. Hillman, G.P. Haas, S. Sud, and R.K. Puri Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4 J. Clin. Invest. 91 1993 88 93 (Pubitemid 23037257)
13. N.I. Obiri, J.P. Siegel, F. Varricchio, and R.K. Puri Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells Clin. Exp. Immunol. 95 1994 148 155 (Pubitemid 24207118)
14. H.Y. Hong, H.Y. Lee, W. Kwak, J. Yoo, M.H. Na, I.S. So, T.H. Kwon, H.S. Park, S. Huh, G.T. Oh, I.C. Kwon, I.S. Kim, and B.H. Lee Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis J. Cell. Mol. Med. 12 2008 2003 2014
15. H. Lee, B. Hoang, H. Fonge, R.M. Reilly, and C. Allen In vivo distribution of polymeric nanoparticles at the whole-body, tumor, and cellular levels Pharm. Res. 27 2010 2343 2355
16. S.M. Moghimi, A.C. Hunter, and J.C. Murray Long-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 2001 283 318 (Pubitemid 32476118)
17. J. Hyung Park, S. Kwon, M. Lee, H. Chung, J.H. Kim, Y.S. Kim, R.W. Park, I.S. Kim, S. Bong Seo, I.C. Kwon, and S. Young Jeong Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity Biomaterials 27 2006 119 126 (Pubitemid 41225375)
18. J.H. Kim, Y.S. Kim, K. Park, S. Lee, H.Y. Nam, K.H. Min, H.G. Jo, J.H. Park, K. Choi, S.Y. Jeong, R.W. Park, I.S. Kim, K. Kim, and I.C. Kwon Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice J. Control. Release 127 2008 41 49
19. J.H. Park, S. Kwon, J.O. Nam, R.W. Park, H. Chung, S.B. Seo, I.S. Kim, I.C. Kwon, and S.Y. Jeong Self-assembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid for RGD peptide delivery J. Control. Release 95 2004 579 588 (Pubitemid 38340507)
20. X.L. Wu, J.H. Kim, H. Koo, S.M. Bae, H. Shin, M.S. Kim, B.H. Lee, R.W. Park, I.S. Kim, K. Choi, I.C. Kwon, K. Kim, and D.S. Lee Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy Bioconjugate Chem. 21 2010 208 213
21. K. Kawakami, M. Kawakami, P. Leland, and R.K. Puri Internalization property of interleukin-4 receptor alpha chain increases cytotoxic effect of interleukin-4 receptor-targeted cytotoxin in cancer cells Clin. Cancer Res. 8 2002 258 266 (Pubitemid 34101486)
22. S. Dhar, F.X. Gu, R. Langer, O.C. Farokhzad, and S.J. Lippard Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles Proc. Natl. Acad. Sci. U. S. A. 105 2008 17356 17361
23. A.L. Lee, Y. Wang, H.Y. Cheng, S. Pervaiz, and Y.Y. Yang The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles Biomaterials 30 2009 919 927
24. F. Pastorino, C. Brignole, D. Di Paolo, B. Nico, A. Pezzolo, D. Marimpietri, G. Pagnan, F. Piccardi, M. Cilli, R. Longhi, D. Ribatti, A. Corti, T.M. Allen, and M. Ponzoni Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy Cancer Res. 66 2006 10073 10082 (Pubitemid 44672061)
25. D.B. Kirpotin, D.C. Drummond, Y. Shao, M.R. Shalaby, K. Hong, U.B. Nielsen, J.D. Marks, C.C. Benz, and J.W. Park Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res. 66 2006 6732 6740 (Pubitemid 44085631)
26. T.R. Shockley, K. Lin, J.A. Nagy, R.G. Tompkins, H.F. Dvorak, and M.L. Yarmush Penetration of tumor tissue by antibodies and other immunoproteins Ann. N. Y. Acad. Sci. 618 1991 367 382
27. G.P. Adams, R. Schier, A.M. McCall, H.H. Simmons, E.M. Horak, R.K. Alpaugh, J.D. Marks, and L.M. Weiner High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules Cancer Res. 61 2001 4750 4755 (Pubitemid 32691886)
28. M.M. Schmidt, and K.D. Wittrup A modeling analysis of the effects of molecular size and binding affinity on tumor targeting Mol. Cancer Ther. 8 2009 2861 2871
29. D.M. Vail, M.A. Amantea, G.T. Colbern, F.J. Martin, R.A. Hilger, and P.K. Working Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studies Semin. Oncol. 31 2004 16 35 (Pubitemid 40023240)